DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 212 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2022. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $540,360 | +15.9% | 36,585 | +1.4% | 0.01% | +25.0% |
Q2 2023 | $466,218 | +35.3% | 36,085 | +2.8% | 0.00% | +33.3% |
Q1 2023 | $344,517 | -4.5% | 35,119 | +3.6% | 0.00% | 0.0% |
Q4 2022 | $360,728 | +6.1% | 33,903 | +4.0% | 0.00% | -25.0% |
Q3 2022 | $340,000 | -12.6% | 32,609 | +5.6% | 0.00% | 0.0% |
Q2 2022 | $389,000 | +10.8% | 30,882 | -4.8% | 0.00% | +33.3% |
Q1 2022 | $351,000 | -19.3% | 32,425 | +5.0% | 0.00% | 0.0% |
Q4 2021 | $435,000 | -27.5% | 30,887 | -1.0% | 0.00% | -40.0% |
Q3 2021 | $600,000 | +98.0% | 31,213 | +1.4% | 0.01% | +150.0% |
Q2 2021 | $303,000 | +6.7% | 30,786 | +6.7% | 0.00% | 0.0% |
Q1 2021 | $284,000 | +123.6% | 28,864 | +1.0% | 0.00% | +100.0% |
Q4 2020 | $127,000 | +1.6% | 28,582 | -0.9% | 0.00% | 0.0% |
Q3 2020 | $125,000 | -34.6% | 28,836 | +33.7% | 0.00% | -66.7% |
Q2 2020 | $191,000 | +172.9% | 21,570 | +9.6% | 0.00% | +200.0% |
Q1 2020 | $70,000 | – | 19,689 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |